SPONTANEOUS RELIEF OF VITREOMACULAR TRACTION AND REGRESSION OF NEOVASCULARIZATION IN EALES DISEASE AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB

    loading  Checking for direct PDF access through Ovid

Abstract

Purpose:

To report the use and sequelae of intravitreal injection of bevacizumab (Avastin; Roche) in Eales disease with persistent active neovascularization and vitreomacular traction.

Methods:

Intravitreal injection of bevacizumab was used to treat Eales disease with a persistent large neovascular frond, vitreous hemorrhage, and vitreomacular traction.

Results:

After the injection, there was spontaneous relief of the vitreomacular traction and improvement in visual acuity. Rapid regression of the neovascular frond resulted in a traction retinal break, which was successfully managed with barrage laser photocoagulation.

Conclusion:

Intravitreal injection of bevacizumab seems to be a good option in managing persistent neovascularization in Eales disease. These patients need regular follow-up to recognize the complications that may arise due to the rapid regression of neovascularization.

Related Topics

    loading  Loading Related Articles